Q98127185
proposition in the Riksdag 2013
Press Enter · cited answer in seconds
0 sources
Q98127185
Summary
Q98127185 is a bill[1].
Key Facts
- Q98127185's instance of is recorded as bill[2].
- Q98127185's part of the series is recorded as propositions of the 2012-2013 legislative session of the Riksdag[3].
- Q98127185's language of work or name is recorded as Swedish[4].
- Q98127185 was released on +2013-04-03T00:00:00Z[5].
- Q98127185's main subject is medication[6].
- Q98127185's work available at URL is recorded as http://data.riksdagen.se/dokument/H003118[7].
- Q98127185's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H003118[8].
- Q98127185's work available at URL is recorded as http://data.riksdagen.se/fil/CA9B84B6-0276-4804-9BA2-9D3F46E91DA1[9].
- Q98127185's applies to jurisdiction is recorded as Sweden[10].
- Q98127185's legal citation of this text is recorded as Prop. 2012/13:118[11].
- Q98127185's title is recorded as Genomförande av ändringsdirektiv 2012/26/EU i fråga om säkerhetsövervakning av läkemedel[12].
- Q98127185's cites work is recorded as Q98126976[13].
- Q98127185's cites work is recorded as Q98138279[14].
- Q98127185's cites work is recorded as Q98409206[15].
- Q98127185's maintained by WikiProject is recorded as Project Riksdagen's documents[16].
- Q98127185's copyright status is recorded as public domain[17].
- Q98127185's legislative committee is recorded as Committee on Health and Welfare[18].
Body
Definition and Type
Q98127185's instance of is recorded as bill[2].